Dr Faraidoon Haghdoost | UNSW Research

Researcher

Keywords

headache disorders

cluster headache

systematic review

clinical trials

Biography

Faraidoon Haghdoost (MD, PhD), from Kurdistan in Iran, is a research fellow in headache disorders at The George Institute for Global Health, University of New South Wales (UNSW), Sydney, Australia. Faraidoon is interested in studying headache disorders, especially migraine disease, tension-type headache and cluster headache, contributing to growing awareness of the need for headache-specific research and starting a headache-specific research...view more

Faraidoon Haghdoost (MD, PhD), from Kurdistan in Iran, is a research fellow in headache disorders at The George Institute for Global Health, University of New South Wales (UNSW), Sydney, Australia. Faraidoon is interested in studying headache disorders, especially migraine disease, tension-type headache and cluster headache, contributing to growing awareness of the need for headache-specific research and starting a headache-specific research group based on headache patients’ needs.
Faraidoon is passionate about engaging with scientists, healthcare providers and people with headache disorders through social media and other communication platforms. He is highly skilled in clinical trials and meta-analysis, study design, statistical data analysis, communication, lecturing, and presentations.

Other interests: science comedy

My Grants

Novel Treatments and Management Strategies for Chronic Pain stream of the Australian Medical Research Future Fund (MRFF), Psilocybin Efficacy and Acceptability on Cluster Headache Episodes’ (PEACE) pilot trial. More information

My Qualifications

PhD.The George Institute for Global Health, University of New South Wales (UNSW), New South Wales, Sydney, Australia. 2019 - 2023

MD, school of medicine, Isfahan University of Medical Sciences, Isfahan, Iran. 2006 - 2014

My Awards

Peter Goadsby Award, best scientific oral abstract presentation at the Australian and New Zealand Headache Society Annual Scientific Meeting (ANZHS2025), Sydney.

iHEAD grant, Awarded funding to attend the 8th iHEAD meeting and the International Headache Congress (IHC2023), in Seoul, South Korea.

IHS Short-stay scholarship by International Headache Society, July 2020

iHEAD grant, Awarded funding to attend the iHEAD meeting and 19th Congress of the International Headache Society (IHC2019), in Dublin, Ireland.

Scientia PhD Scholarship, University of New South Wales (UNSW).

Travel Grant, 17th Migraine Trust International Symposium (MTIS)

My Research Activities

All Publications

Link to PubMed Page

Selected publications

Khalili M, Haghdoost F (co-first), Liaghatdar A, Torabiardakani K, Mahdian F, Levit T, et al. Effectiveness and Tolerability of Pharmacologic Prophylaxis for Chronic Migraine : A Systematic Review of Randomized Controlled Trials. Ann Intern Med. 2026 May 5. doi: 10.7326/ANNALS-25-02221. Epub ahead of print. PMID: 42081823.

Haghdoost F, Bahceci D, Delcourt C, Wijeratne T, Jensen RH, Cincinnato C, et al. Patient perspectives on research gaps in cluster headache. Headache: The Journal of Head and Face Pain. 2026; 00: 1-11. DOI: 10.1111/head.70031

Ornello R, Maassen van den Brink A, Puledda F, Sandoe CH, Iannone LF, Pelzer N, Lee MJ, Haghdoost F, et al. Migraine management during pregnancy, breastfeeding and in women planning pregnancy. Cephalalgia. 2025 Nov;45(11):3331024251393945. doi: 10.1177/03331024251393945. Epub 2025 Nov 20.

Nasirzadeh, A.; Ghasemi, A.; Afshari-Safavi, A.; Nahayati, M.A.; Jahanshahi, R.; Yavari, E.; Farzan, M.; Farzan, M.; Bayati, A.; Haghdoost, F. The Validation of the Persian Version of the ID-Migraine Questionnaire. Med. Sci. 2025, 13, 213. https://doi.org/10.3390/medsci13040213

Carcel C, Haghdoost F (co-first), Davies L, Cordato D, Griffiths L, Balicki G, Li Q, Freed R, Anderson CS, Zagami AS, Delcourt C and Rodgers A (2025) Blood pressure lowering for prevention of episodic migraine: results of a pilot randomized, placebo-controlled trial of combination blood pressure lowering medication with propranolol. Front. Neurol. 16:1630732. doi: 10.3389/fneur.2025.1630732

Haghdoost, F.; Salam, A.; Seyed-Kolbadi, F.Z.; Padala, D.; Delcourt, C.; Rodgers, A. Transcranial Direct Current Stimulation in Episodic Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Med. Sci. 2025, 13, 84. https://doi.org/10.3390/medsci13030084

Sacco S, Ashina M, Diener HC, Haghdoost F, et al. Setting higher standards for migraine prevention: A position statement of the International Headache Society. Cephalalgia. 2025 Feb;45(2):3331024251320608. doi: 10.1177/03331024251320608.

Kohandel Gargari O, Aghajanian S, Togha M, Mohammadifard F, Abyaneh R, Mobader Sani S, Samiee R, Kermanpour A, Seighali N, Haghdoost F. Preventive Medications in Pediatric Migraine: A Network Meta-Analysis. JAMA Netw Open. 2024 Oct 1;7(10):e2438666.

Haghdoost, F., Gnanenthiran, S.R., Shan, S. et al. The effect of salt substitution on frequency and severity of headache: results from the SSaSS cluster-randomised controlled trial of 20,995 participants. Eur J Clin Nutr (2024).

Carcel, Cheryl, Faraidoon Haghdoost (co-first), Joanne Shen, Puneet Nanda, Yu Bai, Emily Atkins, Takako Torii-Yoshimura et al. The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis. Cephalalgia 43, no. 6 (2023): 03331024231183166.

Haghdoost F, Puledda F, Garcia-Azorin D, Huessler EM, Messina R, Pozo-Rosich P. Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia. 2023 Apr;43(4):3331024231159366.

Puledda F, Younis S, Huessler EM, Haghdoost F, Lisicki M, Goadsby PJ, Tassorelli C. Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature. Cephalalgia. 2023 Mar;43(3):3331024231151419.

Haghdoost F, Togha M. Migraine management: Non-pharmacological points for patients and health care professionals. Open Medicine 2022;17(1):1869-82.

My Research Supervision

Areas of supervision

Headache disorders

Location

Medicine & Health

The George Institue for Global Health

Contact

fhaghdoost@georgeinstitute.org.au

Follow

My ResearchGate

My Google Scholar

Publications

by Dr Faraidoon Haghdoost

View all »

ORCID as entered in ROS

https://orcid.org/0000-0003-3912-5874

Videos

Join the conversation